GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Trading 02-23 09:39:13 EST

59.48

-0.04

-0.07%

High59.50	Low59.14	Vol563.48K
Open59.27	D1 Closing59.52	Amplitude0.60%
Mkt Cap121.22B	Tradable Cap115.80B	Total Shares2.04B
T/O33.44M	T/O Rate0.03%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":59.48,"timestamp":1771857549877,"preClose":59.52,"halted":0,"volume":563478,"delay":0,"changeRate":-0.0006720430107527932,"floatShares":1946891708,"shares":2037944753,"eps":3.736205,"marketStatus":"Trading","change":-0.04,"latestTime":"02-23 09:39:13 EST","open":59.27,"high":59.5,"low":59.14,"amount":33443074.061436,"amplitude":0.006048,"askPrice":59.49,"askSize":270,"bidPrice":59.47,"bidSize":220,"shortable":3,"etf":0,"ttmEps":3.736205,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":59.52,"dividendRate":0.029319,"preHourTrading":{"tag":"盘前","latestPrice":59.26,"preClose":59.52,"latestTime":"09:29 EST","volume":178187,"amount":10574521.769960001,"timestamp":1771856999261,"change":-0.26,"changeRate":-0.004368,"amplitude":0.004536},"postHourTrading":{"tag":"盘后","latestPrice":59.6,"preClose":59.52,"latestTime":"19:43 EST","volume":23442,"amount":1395457.7504,"timestamp":1771634597217,"change":0.08,"changeRate":0.001344,"amplitude":0.004536},"volumeRatio":3.701595,"impliedVol":0.3147,"impliedVolPercentile":0.7171},"requestUrl":"/m/hq/s/GSK/tweets","defaultTab":"tweets","newsList":[{"id":"1131234092","title":"Frontier Biotechnologies Inks Licensing Agreement with GSK for siRNA Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1131234092","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131234092?lang=en_us&edition=fundamental","pubTime":"2026-02-23 17:03","pubTimestamp":1771837423,"startTime":"0","endTime":"0","summary":"Frontier Biotechnologies Inc. (688221.SH) has announced the signing of an exclusive licensing agreement with global biopharmaceutical company GlaxoSmithKline PLC (GSK). Under this agreement, GSK will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK4588","BK4532","GSK.UK","GSK","688221","BK4007","LU1829250122.USD","BK4585","GSKH"],"gpt_icon":0},{"id":"2613296634","title":"GSK price target raised to 1,900 GBp from 1,780 GBp at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2613296634","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613296634?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:51","pubTimestamp":1771606292,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on GSK (GSK) to 1,900 GBp from 1,780 GBp and keeps an Underweight rating on the shares. Published first on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1900-gbp-from-1780-gbp-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1900-gbp-from-1780-gbp-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2612229317","title":"GSK Director Wendy Becker Increases Stake with Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2612229317","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612229317?lang=en_us&edition=fundamental","pubTime":"2026-02-20 23:33","pubTimestamp":1771601597,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK plc disclosed that independent non-executive director Wendy Becker purchased 3,334 or...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-director-wendy-becker-increases-stake-with-share-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-director-wendy-becker-increases-stake-with-share-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","LU1829250122.USD","GSK.UK","BK4588","GSKH","GSK","BK4532"],"gpt_icon":0},{"id":"2612257467","title":"GlaxoSmithKline (GSK) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2612257467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612257467?lang=en_us&edition=fundamental","pubTime":"2026-02-20 15:55","pubTimestamp":1771574142,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £19.00. Gordon CFA covers the Healthc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","CFA","BK4007","BK4585","GSK.UK","GSK","LU1829250122.USD"],"gpt_icon":0},{"id":"2612257415","title":"GSK lifts treasury stake with latest £10.5m share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2612257415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612257415?lang=en_us&edition=fundamental","pubTime":"2026-02-20 15:46","pubTimestamp":1771573618,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has repurchased 470,000 of its ordinary shares on 19 February 2026 via BNP P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-lifts-treasury-stake-with-latest-10-5m-share-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-lifts-treasury-stake-with-latest-10-5m-share-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US12M.BOND","LU1829250122.USD","BK4588","US10Y.BOND","TMF","BK4007","US2Y.BOND","GSK","US6M.BOND","GSK.UK","BK4585","US7Y.BOND","US3Y.BOND","US30Y.BOND","US5Y.BOND","TLTW","BK4532"],"gpt_icon":0},{"id":"2612286109","title":"GSK Reports Deferred Award Payout to Chief Scientific Officer Tony Wood","url":"https://stock-news.laohu8.com/highlight/detail?id=2612286109","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612286109?lang=en_us&edition=fundamental","pubTime":"2026-02-19 23:32","pubTimestamp":1771515146,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK disclosed that its Chief Scientific Officer, Tony Wood, received a cash payment following t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-reports-deferred-award-payout-to-chief-scientific-officer-tony-wood?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-reports-deferred-award-payout-to-chief-scientific-officer-tony-wood?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK.UK","LU1829250122.USD","GSK","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2612692407","title":"GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2612692407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612692407?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:36","pubTimestamp":1771504583,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £19.00. Accor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4566","GSK.UK","BK4007","BK4588","BK4532","BK4118","GSK","BK4552","LU1829250122.USD","DB"],"gpt_icon":0},{"id":"2612427213","title":"ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612427213","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612427213?lang=en_us&edition=fundamental","pubTime":"2026-02-19 06:55","pubTimestamp":1771455351,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as shareh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viiv-healthcare-says-cabenuva-demonstrated-superior-efficacy-in-latitude-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viiv-healthcare-says-cabenuva-demonstrated-superior-efficacy-in-latitude-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","LU1883839398.USD","LU0289739699.SGD","LU1066053197.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","XBI","GSK","SG9999003800.SGD","LU1894683264.USD","LU1066051498.USD","BK4599","LU0225284248.USD","SGXZ57979304.SGD","BK4588","LU0170899867.USD","BK4533","BK4568","LU0234572021.USD","LU0321505439.SGD","BK4007","IE00BLSP4239.USD","LU0128526141.USD","SG9999011175.SGD","LU0306806265.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU0058720904.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4585","GSK.UK","IE00BLSP4452.SGD","LU0029874061.USD","BK4534","LU1023059063.AUD","SG9999001176.SGD","BK4532","LU0985481810.HKD","BK4550","SG9999013999.USD","LU0122379950.USD","LU1829250122.USD","LU1894683348.USD","LU0225771236.USD","SG9999001176.USD","SG9999002232.USD","BK4137","LU0306807586.USD","BK4581","BK4592","IE0002270589.USD","LABU","LU1057294990.SGD","LU0456855351.SGD"],"gpt_icon":0},{"id":"2612119404","title":"GSK Adds 420,000 Shares to Treasury in Latest Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2612119404","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612119404?lang=en_us&edition=fundamental","pubTime":"2026-02-18 16:51","pubTimestamp":1771404667,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK plc has repurchased 420,000 ordinary shares at a volume‑weighted average pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-420000-shares-to-treasury-in-latest-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-420000-shares-to-treasury-in-latest-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4532","BK4585","GSK.UK","BK4588","GSK","BK4007"],"gpt_icon":0},{"id":"2612469394","title":"GSK Rises Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2612469394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612469394?lang=en_us&edition=fundamental","pubTime":"2026-02-18 01:05","pubTimestamp":1771347900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares advanced 2.52% to GBP22.39 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.79% to 10,556.17.GSK PLC hit a new 52-week high, surpassing its previous peak of GBP22.19, which the company reached on February 9th.Trading volume totaled 6.6 million, compared to the 50-day average of 8.4 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2612465601","title":"European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465601","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465601?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:55","pubTimestamp":1771343751,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were marginally lower late Tuesday morning, edging 0.12% lower to 1,816.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lender Banco Santander  and biopharmaceutical company Cellectis , which advanced 3.4% and 2.1%, respectively. They were followed by biopharmaceutical company Grifols  and lender ING , which increased 1.8% each.The decliners from continental Europe were led by internet advertising firm Criteo  and biotech company Evaxion , which dropped 6.3% and 5.7%, respectively. They were followed by semiconductor company Sequans Communications  and biopharmaceutical company DBV Technologies , which lost 5.6% and 3.1%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals  and Akari Therapeutics , which rose 15.5% and 5.8%, respectively. They were followed by pharmaceutical company GSK  and cruise line operator Carnival","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVAX","SAN","SQNS","BK4142","BK4139","LU1829250122.USD","IHG","BK7141","WPP","CUK","WPP.AU","BK4169","BK4207","ING.AU","BK4107","BK7142","AKTX","BK4521","DBVT","BK4007","DEO","BDRX","DGE.UK","ING","GSK.UK","GRFS","BCYC","BK4532","IE00BFMHRM44.USD","CLLS","SAN.AU","BK4009","BK4585","AFG","BK7505","CRTO","BK4141","GSK","BK4559","BK4117","BK4588"],"gpt_icon":0},{"id":"2612465359","title":"GSK Discloses ADS Vesting and Tax-Related Share Sale by U.S. President","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465359","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465359?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:32","pubTimestamp":1771342379,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has disclosed that Maya Martinez-Davis, its President for the U.S. business, received the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-ads-vesting-and-tax-related-share-sale-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-ads-vesting-and-tax-related-share-sale-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","LU1829250122.USD","GSK.UK","BK4585","BK4007","GSK"],"gpt_icon":0},{"id":"2612465841","title":"GSK executive awards vest at 82% after strong sales, profit and ESG performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465841","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465841?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:32","pubTimestamp":1771342362,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has disclosed the vesting of awards under its 2017 Performance Share Plan for senior ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executive-awards-vest-at-82-after-strong-sales-profit-and-esg-performance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executive-awards-vest-at-82-after-strong-sales-profit-and-esg-performance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESG","GSK"],"gpt_icon":0},{"id":"2612146806","title":"GSK Says European Commission Approved Exdensur as Add-on Severe Asthma, Chronic Rhinosinusitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2612146806","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612146806?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:54","pubTimestamp":1771340076,"startTime":"0","endTime":"0","summary":"GSK  said Tuesday that the European Commission has approved Exdensur as an add-on maintenance treatment for severe asthma with type 2 inflammation and as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.The Commission's approval was based on data from the Swift and Anchor phase 3 trials, in which each of the four trials achieved their primary or co-primary endpoints \"with statistically significant and clinically meaningful results,\" the company said.Shares of the company were up 2.7% in early Tuesday trading.Price: 60.54, Change: +1.61, Percent Change: +2.73","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","BK4585","BK4007","GSK","GSK.UK","BK4532","BK4588"],"gpt_icon":0},{"id":"2612845421","title":"GSK’s announces new data for Arexvy at RSVVW’26","url":"https://stock-news.laohu8.com/highlight/detail?id=2612845421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612845421?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:36","pubTimestamp":1771331774,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced new effectiveness data for its adjuvanted recombinant respiratory syncytial virus vaccine at RSVVW’26, the 9th Conference of th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-announces-new-data-for-arexvy-at-rsvvw26-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-announces-new-data-for-arexvy-at-rsvvw26-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","LU1829250122.USD","BK4007","BK4532","BK4588","BK4585","GSK.UK"],"gpt_icon":0},{"id":"2612459684","title":"Europe Clears GSK's New Twice-Yearly Asthma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2612459684","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612459684?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:31","pubTimestamp":1771327860,"startTime":"0","endTime":"0","summary":"EU approves GSK's Exdensur for severe asthma and nasal polyps, offering twice-yearly dosing and fewer attacks in trials.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/17/Boy-Using-Nasal-Spray-Bottle---Allergy-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/17/Boy-Using-Nasal-Spray-Bottle---Allergy-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/02/50643823/europe-clears-gsks-new-twice-yearly-asthma-treatment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50643823/europe-clears-gsks-new-twice-yearly-asthma-treatment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["GSK","BK4532","GSK.UK","BK4585","LU1829250122.USD","BK4588","BK4007"],"gpt_icon":0},{"id":"2612443089","title":"Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612443089","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612443089?lang=en_us&edition=fundamental","pubTime":"2026-02-17 15:25","pubTimestamp":1771313121,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst Kerry Holford maintained a Hold rating on GlaxoSmithKline today and set a price target of £20.00. Holford covers the Healthc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2612374744","title":"GSK Wins EU Nod for First Ultra-Long-Acting Biologic in Severe Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2612374744","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612374744?lang=en_us&edition=fundamental","pubTime":"2026-02-17 15:18","pubTimestamp":1771312726,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has secured European Commission approval for Exdensur (depemokimab), the fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-wins-eu-nod-for-first-ultra-long-acting-biologic-in-severe-asthma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-wins-eu-nod-for-first-ultra-long-acting-biologic-in-severe-asthma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","LU1829250122.USD","BK4156","BK4007","BK4585","GSK","GSK.UK"],"gpt_icon":0},{"id":"2611948966","title":"GSK Ties 2026 Executive Share Awards to Growth, Pipeline and TSR Benchmarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2611948966","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611948966?lang=en_us&edition=fundamental","pubTime":"2026-02-16 23:32","pubTimestamp":1771255979,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has granted 2026 performance share plan awards to senior executives, including CEO Luke ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-ties-2026-executive-share-awards-to-growth-pipeline-and-tsr-benchmarks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-ties-2026-executive-share-awards-to-growth-pipeline-and-tsr-benchmarks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4588","BK4585","GSK.UK","GSK","BK4532","BK4007"],"gpt_icon":0},{"id":"2611489667","title":"GSK Grants Long-Term Notional Share Awards to New Executive Committee Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2611489667","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611489667?lang=en_us&edition=fundamental","pubTime":"2026-02-16 23:32","pubTimestamp":1771255961,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has granted notional share awards under its Deferred Investment Award programme to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-grants-long-term-notional-share-awards-to-new-executive-committee-members?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-grants-long-term-notional-share-awards-to-new-executive-committee-members?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","BK4585","LU1829250122.USD","GSK","BK4588","GSK.UK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.2382},{"period":"3month","weight":0.2613},{"period":"6month","weight":0.481},{"period":"1year","weight":0.6104},{"period":"ytd","weight":0.2137}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001408},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.673913,"avgChangeRate":0.032633},{"month":5,"riseRate":0.413043,"avgChangeRate":-0.008096},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}